Francois Nader
CIK 1365343 · President, CEO and Director · last filed 2026-05-08
Francois Nader is a President, CEO and Director who has filed 85 SEC Form 4 insider transactions across 9 companies since 2007. The most recent filing, for MRNA, was dated May 8, 2026. Across all open-market trades the lifetime net is −$10.8M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.6M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.64M
9
85
-$10.78M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MRNA | Director | 32,781 | $49.91 | $1.64M | -$435.0K | 10 | 2026-05-08 |
| TECX | Director | — | $30.28 | — | $0 | 1 | 2026-04-03 |
| Tourmaline Bio, Inc. (TALS) Delisted | Director | 285,755 | $27.20 | $7.77M | $1.00M | 5 | 2023-06-14 |
| ACCELERON PHARMA INC (XLRN) Delisted | Director | 0 | $178.75 | $0 | $0 | 11 | 2021-11-22 |
| Prevail Therapeutics Inc. (PRVL) Delisted | Director | 23,747 | — | — | $0 | 2 | 2020-06-19 |
| Baxalta Inc (BXLT) Delisted | Director | 7,657 | — | — | $0 | 2 | 2016-05-12 |
| TRVN | Director | — | $0.01 | — | $0 | 2 | 2015-05-21 |
| NPS PHARMACEUTICALS INC (NPSP) Delisted | President, CEO and Director | 0 | — | — | -$11.35M | 41 | 2015-02-24 |
| NOVEN PHARMACEUTICALS INC (NOVN) Delisted | Director | 0 | $0.09 | $0 | $0 | 3 | 2009-08-27 |
Recent Filings
85 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-08 | MRNA | Grant (A) | — | $0 | EDGAR |
| 2026-05-04 | MRNA | Exer (M) | +12,174 | $0 | EDGAR |
| 2026-04-03 | TECX | Grant (A) | — | $0 | EDGAR |
| 2025-05-01 | MRNA | Grant (A) | — | $0 | EDGAR |
| 2024-05-07 | MRNA | Grant (A) | — | $0 | EDGAR |
| 2023-06-14 | Tourmaline Bio, Inc. (TALS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-05-05 | MRNA | Grant (A) | — | $0 | EDGAR |
| 2022-09-13 | Tourmaline Bio, Inc. (TALS) Delisted | Mixed | +138,500 | $500.0K | EDGAR |
| 2022-07-25 | Tourmaline Bio, Inc. (TALS) Delisted | Mixed | +138,500 | $500.0K | EDGAR |
| 2022-06-13 | Tourmaline Bio, Inc. (TALS) Delisted | Grant (A) | — | $0 | EDGAR |